Moneycontrol
HomeNewsOpinionIf there is one toolkit the govt must pay attention to, it's the IMF’s vaccination plan

If there is one toolkit the govt must pay attention to, it's the IMF’s vaccination plan

Manas Chakravarty   •

The US alone has 80 million surplus doses available to donate as of April 2021 and this surplus stockpile will grow to around 350 million doses by the end of August 2021. That makes foreign minister S Jaishankar’s trip to the US of crucial importance in easing India’s vaccine shortage 

Bharat Biotech, the Hyderabad-based COVID-19 vaccine maker, recently received approval from the Drugs Controller General of India to conduct clinical trials on children between the age of 2 and 18 (Representative image: PTI)

To read the full story,

Subscribe to Moneycontrol PRO
  • Ad-free Experience
  • Access Exclusive Stories
  • Weekly Investment Ideas
  • Daily Technical Calls

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

View Offers

Unlock exclusive discounts